# ReoPro and Retavase to Restore Brain Blood Flow After Stroke

> **NCT00039832** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 42 (actual)

## Conditions studied

- Cerebrovascular Accident

## Interventions

- **DRUG:** Abciximab (ReoPro) and Reteplase (Retavase)

## Key facts

- **NCT ID:** NCT00039832
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2007-04
- **Final completion:** 2008-05
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2011-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00039832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00039832, "ReoPro and Retavase to Restore Brain Blood Flow After Stroke". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00039832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*